Inflammatory Arthritis in Clinical Practice: A Handbook of Inflammatory Arthritis - Softcover

Über die Autorin bzw. den Autor

David L Scott is Professor of Clinical Rheumatology at King’s College School of Medicine, London, UK. He also leads the clinical service at King’s College Hospital, London. His medical training was in Leeds, and he was introduced to rheumatology by working with Professor Verna Wright. He subsequently spent some years in Birmingham, completing research training for his MD with Professor Kenneth Walton and Professor Paul Bacon. He was an ARC and Wellcome Trust travelling fellow in the US and Europe and subsequently held the Muir Hambro Fellowship of the Royal College of Physicians. His research focuses on the treatment and outcome of arthritis, and he has written over 250 papers and been involved in 25 books in the field. He spent 5 years as editor of Rheumatology and is currently honorary Heberden Librarian at the British Society for Rheumatology. He is involved with many patient groups including Arthritis Care and the Arthritis and Musculoskeletal Alliance. He also serves on the Disability Living Allowance Advisory Board of the Department of Work and Pensions.

Von der hinteren Coverseite

Inflammatory Arthritis in Clinical Practice is intended primarily as a concise practical handbook for general practitioners, rheumatology doctors in training and those in related specialties like orthopaedics. It will also be of interest to specialist nurses and allied health professionals working in the field.

It covers all aspects of the diagnosis and management of rheumatoid arthritis and spondyloarthropathies with chapters on

• Rheumatoid arthritis pathogenesis, clinical features, laboratory investigations, imaging, predicting outcomes and health economics

• Spondyloarthropathies pathogenesis, clinical features, laboratory investigations and imaging followed by individual sections on each spondyloarthropathy

• Symptomatic Drug Treatment analgesics and non-steroidal anti-inflammatory drugs including coxibs

• Disease Modifying Antirheumatic Drugs methotrexate, leflunomide and other conventional DMARDs, combination therapy, current best practice

• Biologics in Rheumatoid Arthritis tumour necrosis factor inhibitors and other novel biologics, health economics

• Systemic and Local Steroids

• Non-pharmacological therapy multidisciplinary approach, communication and patient education, physiotherapy, occupational therapy, podiatry, surgery, dietary interventions and complementary therapies